Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Aug;16(7):350-4.
doi: 10.1023/a:1020585728549.

The effect of hydrosalpinges on IVF-ET outcome

L I Barmat  1 , E Rauch, S Spandorfer, A Kowalik, E S Sills, G Schattman, H C Liu, Z Rosenwaks
Affiliations
Clinical Trial

The effect of hydrosalpinges on IVF-ET outcome

L I Barmat et al. J Assist Reprod Genet. 1999 Aug.

Abstract

Purpose: Our purpose was to determine if the presence of a hydrosalpinx effects the outcome of in vitro fertilization (IVF)-embryo transfer.

Methods: We performed a retrospective analysis of IVF cycle stimulation sheets.

Results: A total of 1000 patients with tubal factor infertility was analyzed. There were 60 hydrosalpinx patients who underwent 116 initiated cycles with 106 embryo transfers, compared to 940 control patients undergoing 1428 initiated cycles with 1150 embryo transfers. Both groups had a similar response to ovarian stimulation, number of oocytes retrieved, and number of embryos transferred. The hydrosalpinx group had a significantly higher preclinical loss rate (22/59 = 37% vs 80/566 = 14%; P = 0.001), a significantly lower implantation rate (55/352 = 16% vs 795/3795 = 21%; P = 0.013), a trend toward a reduced delivery rate per transfer (28/106 = 26% vs 387/1150 = 34%; P = 0.066), a significantly higher ectopic pregnancy rate (5/59 = 8% vs 16/566 = 3%; P = 0.04), and a similar spontaneous abortion rate (9/37 = 24% vs 99/486 = 20%; P = 0.28) compared to the control tubal factor group.

Conclusions: This study demonstrates a decrease in implantation rates and an increase in preclinical miscarriages and ectopic pregnancies in patients with hydrosalpinges compared to tubal-factor patients without sonographic evidence of dilated fallopian tubes.

PubMed Disclaimer

References

    1. Edwards RG, Steptoe PC, Purdy JM. Establishing full term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynecol. 1980;87:737–756. - PubMed
    1. Society for Assisted Reproductive TechnologyThe American Society for Reproductive Medicine Assisted reproductive technology in the United States and Canada: 1994 results generated from The American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 1996;66:697–705. - PubMed
    1. Rosenwaks ZR, Davis OK, Damario MA. The role of maternal age in assisted reproduction. Hum Rep. 1995;10(Suppl1):165–172. - PubMed
    1. Check JC, Lurie D, Callan C, Baker A, Benfer Comparison of the cumulative probability of pregnancy after in vitro fertilization-embryo transfer by infertility factor and age. Fertil Steril. 1994;61:257–261. - PubMed
    1. Kassabji M, Simms JA, Butler L, Musasher SJ. Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization. Eur J Obstet Gynecol. 1994;56:129–132. - PubMed

Publication types